NASDAQ$IXHL

Incannex Healthcare Inc · Q1 2025 earnings

Q1 2025 earnings ·

Briefing

IXHL Q1 2025 — $20.0M revenue

Quarterly Report, including statements regarding our future results. Incannex Healthcare Inc reported Q1 2025 results. Net income of $5.4M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.

  • Revenue: $20.0M.
  • Net income: $5.4M.
  • Operating income: $6K.

Headline financials

Total Revenue

$74K

No prior period
EPS

-$0.29

No prior period
Free Cash Flow

-$5.42M

No prior period
Net Income

-$5.42M

No prior period
Operating Income

-$6.25M

No prior period
Gross Profit

$74K

No prior period

Revenue & EPS history

Incannex Healthcare Inc · Revenue · Quarterly

$74K

Q1 2025
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 5 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

-0.9%

Avg return

Earnings day

-3.8%

Avg return

5 days after

-12.2%

Avg return

30 days after

33%

2 / 6 earnings

Positive

+11.8%

Q2 2024

Best reaction

-11.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+1.8%-5.1%-1.8%
Q1 2026-1.4%-6.7%+18.5%
Q2 2025-0.9%-9.8%-58.8%
Q1 2025-11.7%-18.9%-29.8%
Q3 2024-5.2%-16.5%+8.5%
Q2 2024+11.8%+34.4%-9.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro